SEC Tracker
Get the app

AEON Biopharma AEON

AEON Biopharma Biopharma, Inc.: Ownership stake disclosure (amended)

Schedule 13D/A on AEON Biopharma (AEON), filed with the SEC on Nov 10, 2026, 12:13 pm ET. Source: the filing on SEC EDGAR.

Ownership stake disclosure by Daewoong Co., Ltd (amended)

Form
Schedule 13D/A
Filed
Importance
Notable
  1. DWP exercised 11,232,809 shares on Oct 30, 2026
  2. DWP now owns 23,184,523 shares, 30.5% of outstanding
  3. Pre-Funded Warrants no longer outstanding
  4. Issuer's shares increased to 76,009,476 as of Nov 9, 2026

Written from the Schedule 13D/A on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when AEON Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.